A survey conducted by the India office of the international non-governmental organisation, Transparency International, reveals that, according to people’s actual experiences, the health service is the most corrupt service sector in India. It ranks India as one of the 30 most corrupt countries in the world. Indifferent treatment of patients, unofficial payments to providers, lack of patient privacy, and inadequate provision of medicines and supplies are some of the most common demerits and malpractices prevailing in the health services in India.

The survey, conducted with private marketing research company ORG-Marg Research, interviewed some 5000 citizens in a household survey to assess the public’s perception of corruption. It covered 10 sectors with a direct bearing on people’s lives, including education, health, the police, the judiciary, and power utilities.

Too high medicinal cost accompanied by doctor’s consultation fees has made the proper medical treatment to become out of the reach of Indian common man, especially in the rural areas where neither licensed medical stores nor qualified doctors are available and malpractices of the Primary Health Centres, available generally in rural towns only, are well known and are practically forfeiting the veritable purpose of PHC’s there. As a result thereof, not only the market of non-qualitative and banned drugs and medicines is flourishing day by day, but the unqualified doctors also are emerging fast and plundering the poor mass. On account of insufficient availability of generic medicines (patent based medicines which are cheaply produced by another process) the patients are compelled to purchase high priced branded medicines.

An analysis of drug market in India by the ‘World Health Organisation’ (WHO) also reveals that Indian pharmaceutical companies are charging very high prices of medicines from patients. In India, the pharmaceutical companies are earning profits even up to ten times or more of the production cost in case of both branded and unbranded medicines. Not only is this, but the companies, by printing high retail price, are letting the sellers too to earn abnormal profits. Like the ratio between production cost and whole sale price, in many cases the retail price also is ten times or more of the whole sale price. The anti-allergic tablet named as ‘Citrazine’ of ‘Cipla Pharmaceuticals’ is an example. High retail prices of patented and generic medicines are making the general mass to resort to unauthentic and duplicate medicines produced by unlicensed pharmaceutical units. That is why the influence of unauthentic, unlicensed and duplicate medicine producing units in Indian drug market is day by day increasing whereby the people are being badly hit on account of low effectiveness and severe side-effects of the medicines produced by these companies. Many times the doctors too, having been affected by the commission based and gift based sale strategies of the companies producing duplicate medicines, prescribe these medicines without paying heed to the compositions and the bad effects on health on account of the use of these medicines. In some cases the sellers (chemists) let aside the prescription of doctor and sell these medicines especially to the illiterate or docile customers. Not only is this, but the manufacturing companies of these medicines also establish their links even to the government medicine purchasing authorities and seek supply orders. Not only the substandard medicines but even those harmful medicines are being produced and sold in bulks in the Indian market which stand banned at international level.  

Medicines are very precious for human life and have become at present a good part of trade. Therefore, the government should take strong and effective steps to make the qualitative and cheap medicines easily available to the people. The government also should take proper measures against malpractices prevailing in the market of medicines and should instil awareness of medicine consumers against these malpractices. Such organisations should be encouraged which manufacture medicines according to the international standards but at low cost so as to make cheap medicines available in the market. The ‘Low Cost Standard Therapeutics (LOCOST)’ trust at Baroda is a good example of such an organisation. This trust is making cheap production in 90 formulations of about 60 necessary medicines to cater the need of poor and needy patients. Moreover, The launching of the ‘public use medicines easy availability programme’ by the Department of Pharmaceuticals of the central government through 100 public stores of generic drugs, planned to be opened up to December 2009, is worth appreciation.

To solve the problems like that of substandard medicines, harmful and banned medicines and unjustified profit margin a central drugs regulatory system has now become acutely and pressingly needed. The issue of permission as regards to the trading of imported medicines also will be settled by such regulatory system.

The government is encouraging and helping the establishment of small pharmaceutical units. Similar cooperation should be extended to the market extension of their products. The condition of minimum turnover should be relaxed in case of small units. In the present period of prevailing depression the small and medium pharmaceutical industries should be helped through stimulus package to protect them in big market. This type of measures will protect the poor and general medical consumers against their being plundered through high prices by providing them cheap medicines. Moreover, it will help making India a medicine hub.

Studies have shown that health care utilisation has been a long standing concern for most of the developing countries and is sensitive to user perceptions of quality. Patient perceptions of health services thence form an important part of health care quality assessment.  Therefore, ways and means should be found out to give potentiality to important elements of making the health system adequately effective to make health services fully responsive to people’s needs and expectations.

____________________________________________________________

Watch the video related to health services research

Sigma Health Care a home health and disease management organization, headquartered in Galveston Texas was established in 1997 by Amer Taha. Taha started Sigma with aa mission, vision and a philosophy all focused on the fact that health and medical care can be provided in the patient home in a more efficient and organized fashion if technology is introduced and utilized properly. As a result; in 2002, Taha started and directed a research and development Department within the organization. The …

Help answer the question about health services research

About Author

Article Source: ArticlesBase.com – A Note on Health Services and Drug Market in India

By David R. Donohue, M.A.

NATIONAL LIBRARY OF MEDICINE FACT SHEET

The National Library of Medicine (NLM), in Bethesda, Maryland, is a part of the National Institutes of Health, US Department of Health and Human Services (HHS). Since its founding in 1836, NLM has played a pivotal role in translating biomedical research into practice. It is the world’s largest biomedical library and the developer of electronic information services that deliver trillions of bytes of data to millions of users every day. Scientists, health professionals, and the public in the US and around the globe search the Library’s online information resources more than one billion times each year.

The Library is open to all and has many services and resources–for scientists, health professionals, historians, and the general public. NLM has nearly 12 million books, journals, manuscripts, audiovisuals, and other forms of medical information on its shelves, making it the largest health-science library in the world. In today’s increasingly digital world, NLM carries out its mission of enabling biomedical research, supporting health care and public health, and promoting healthy behavior by:

* Acquiring, organizing, and preserving the world’s scholarly biomedical literature;

* Providing access to biomedical and health information across the country in partnership with the 5,600-member National Network of Libraries of Medicine (NN/LM®);

* Serving as a leading global resource for building, curating and providing sophisticated access to molecular biology and genomic information, including those from the Human Genome Project and NIH Roadmap;

* Creating high quality information services relevant to toxicology and environmental health, health services research, and public health;

* Conducting research and development on biomedical communications systems, methods, technologies, and networks and information dissemination and utilization among health professionals, patients, and the general public;

* Funding advanced biomedical informatics research and serving as the primary supporter of pre- and post-doctoral research training in biomedical informatics at 18 US universities. Scientific Information Services:The most frequently consulted online scientific medical resource in the world is MEDLINE®/PubMed®, a publicly available database of over 18 million journal citations from 1948 to the present. Another important part of NLM’s vast online holdings is PubMed Central® (PMC), a Web-based repository of biomedical journal literature providing free, unrestricted access to more than 1.5 million full-text articles. The National Center for Biotechnology Information (NCBI) distributes GenBank®, a collection of all known DNA sequences, and also provides access to the assembled Human Genome data. NCBI also has a prominent role in the important new Genome-Wide Association Studies (GWAS) project, an NIH-wide initiative directed at understanding the genetic factors underlying human disease.

In 2007, NCBI significantly expanded its breadth of public resources by developing the database of Genotypes and Phenotypes (dbGaP). These and other NCBI resources are accessible at http://www.ncbi.nih.gov. It has been 14 years since the Visible Human Project® male and female datasets were released by NLM’s Lister Hill Center. The datasets (some 50 gigabytes in all) are being applied in a wide range of projects by nearly 2,500 licensees in 49 countries. The Specialized Information Services Division (SIS) offers a wide range of resources relating to environmental health and toxicology

. Among the best known is TOXNET®, a collection of databases on hazardous chemicals, toxic releases and environmental health. SIS also compiles information on HIV/AIDS, disaster preparedness and other topics. Information Services for the Public: The Library has extensive information resources to serve the general public.

The Library’s main portal for consumer health information is MedlinePlus®, available in both English and Spanish (MedlinePlus en español). MedlinePlus has comprehensive, up-to-date, easy-to-read information on nearly 800 health topics. It also provides interactive health tutorials and a collection of surgery videos. MedlinePlus features information on thousands of prescription and over-the-counter medicines, as well as alternative treatments such as herbals. And, to provide the public with more health care news it can use, NLM staff oversees the production of the free, quarterly NIH MedlinePlus magazine and its Spanish-language counterpart, NIH MedlinePlus Salud. ClinicalTrials.gov provides the public with comprehensive information about all types of clinical research studies.

The site has over 71,000 protocol records sponsored by the US government, the pharmaceutical industry, and academic and international organizations, in all 50 states and 165 countries. Genetics Home Reference is NLM’s Web site for consumer-friendly health information on genetic conditions. This information resource bridges consumer health information and scientific bioinformatics data, and it links to many existing resources, both at NLM and at other reliable sites. Another information resource for the public is NIHSeniorHealth.gov, which is maintained by the Library in collaboration with the National Institute on Aging and other NIH institutes.

The site features information on topics of interest to seniors, with special features like enlargeable type and a “talking” function that allows users to listen as the text is read to them. NLM has information for the public, too, on toxicology, environmental health, and HIV/AIDS. The Household Products Database, provides easy-to-understand data in consumer-friendly language on the potential health effects of more than 2,000 ingredients contained in more than 7,000 common household products. Tox Town® points out many harmful substances and environmental hazards not only in a town but in a port, a big city, a farm, and the US-Mexico border area.

The Division has also created a series of information portals targeted to special populations, including Native Americans, Asian Americans, and those living in the Arctic. ToxMystery, an interactive Web site for children ages 7-10, teaches users about potential chemical hazards in a home. There is also a Spanish-language version (click on “español”) of this lively interface. National Network of Libraries of Medicine: NLM’s key partner in making information available is the National Network of Libraries of Medicine. The network consists of 5,600 member institutions, including eight Regional Medical Libraries that receive NLM support, 125 resource libraries connected to medical schools, and more than 5,000 libraries located primarily in hospitals and clinics.

Grant Programs:The Extramural Programs Division provides grants to support research in medical informatics, health information science and biotechnology information, as well as for research training in these areas. Network planning and development grants support computer and communications systems in health institutions and the study of new opportunities with high-speed computer networks in the health sciences. Health science library resource grants assist in improving information access and services for health professionals. Research and publications in the history of medicine and the life sciences are also funded. Annual Statistical Profile of NLM: (September 30, 2008)

* Collection (book and nonbook) – 11,890,964

* Items Cataloged – 21,507

* Serial titles received – 20,901

* Articles indexed for MEDLINE – 671,904

* Circulation requests processed – 405,475

* For interlibrary loan – 234,020

* For on-site users – 171,455

* Computerized searches (MEDLINE/PubMed) – 775,504,557

* Budget authority – $323,387,000

* Staff – 699 Visitor Information: http://www.nlm.nih.gov/about/visitor.html Address: 8600 Rockville Pike, Bethesda, MD 20894 Phone (Toll-Free): 888.FIND.NLM (888.346.3656) Tours: Mon.-Fri. (except Federal holidays), 1:30-2:30 PM. Originate in NLM Visitor Center, off first floor lobby of Bldg. 38A, Lister Hill Center.

For group tours of NLM: 301.594.7526. For exhibition tours: 301.594.1947. Reading Room Hours: (Main Reading Room) Mon.-Fri., 8:30 AM-5:00 PM; Sat., 8:30 AM-2:00 PM (except Federal holiday weekends). (History of Medicine Reading Room) Mon.-Fri., 8:30 AM-5:00 PM (except Federal holidays). Holiday Hours: http://www.nlm.nih.gov/about/holiday/html Complete List of NLM Fact Sheets: http://www.nlm.nih.gov/pubs/factsheets/factsheets.html For more information about NLM programs, contact the Office of Communications and Public Liaison (mailing address above), publicinfo@nlm.nih.gov, 301.496.6308, or consult the NLM Web site.

Drop Us a Line: mail@sickcall.us

-30-

Watch the video related to health services research

, health services organization and financing, and health insurance issues. She provided leadership for IOMs Quality Chasm Series which produced ten reports during her tenure including: To Err is Human: Building a Safer Health System and Crossing the Quality Chasm: A New Health System for the 21st Century. Prior to joining IOM in 1998, Dr. Corrigan was Executive Director of the Presidents Advisory Commission on Consumer Protection and Quality in the Health Care Industry. Dr. Corrigan received …

Help answer the question about health services research

About Author

Article Source: ArticlesBase.com – #1 Source For Health and Disease Information